Revascularization Strategies for STEMI; The CMR Endpoint Study
NCT ID: NCT01818960
Last Updated: 2016-07-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
250 participants
INTERVENTIONAL
2014-04-30
2018-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Remote Ischemic Perconditioning in Patients With ST-segment Elevation Myocardial Infarction
NCT02164695
Sonothrombolysis in Patients With STEMI
NCT03092089
Multicenter Cohort of STEMI Patients
NCT03070496
Revascularization StrategIes for ST Elevation Myocardial Infarction Trial
NCT03263468
Prehospital Evaluation and Economic Analysis of Different Coronary Syndrome Treatment Strategies - PREDICT
NCT00747656
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SS-PCI
Same sitting multivessel PCI as an adjunct to primary PCI
SS-PCI
Same sitting multivessel PCI as an adjunct to primary PCI
IRA-PCI
IRA only PCI with planned staging for non-IRA lesions
IRA-PCI
IRA only PCI at the time of Primary PCI
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IRA-PCI
IRA only PCI at the time of Primary PCI
SS-PCI
Same sitting multivessel PCI as an adjunct to primary PCI
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Multivessel CAD as evidenced by ≥1 significant (≥70% by visual assessment or FFR\<0.80 for 50-70% stenosis) stenosis in non-IRA.
* Successful IRA-PCI with \<10% residual angiographic stenosis and TIMI III flow.
* Written informed consent.
Exclusion Criteria
* Prior coronary artery bypass graft (CABG) surgery.
* Administration of thrombolytic therapy.
* Non-IRA stenosis is a chronic total occlusion or located in left main artery.
* Hemodynamic instability evidenced by BP\<90 mmHg, Killip class ≥2, need for inotropes/vasopressors.
* Known renal insufficiency (estimated GFR \< 50ml/min).
* Contraindication to CMR.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Unity Health Toronto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
London Health Sciences
London, Ontario, Canada
St. Michael's Hospital
Toronto, Ontario, Canada
Regina Qu'Appelle Health Region
Regina, Saskatchewan, Canada
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AC-103
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.